S&P 500   3,400.97 (-1.86%)
DOW   27,685.38 (-2.29%)
QQQ   280.47 (-1.50%)
AAPL   115.05 (+0.01%)
MSFT   210.08 (-2.84%)
FB   277.11 (-2.70%)
GOOGL   1,584.29 (-2.98%)
AMZN   3,207.04 (+0.08%)
TSLA   420.28 (-0.08%)
NVDA   525.65 (-3.30%)
BABA   306.87 (-0.98%)
CGC   18.53 (-6.08%)
GE   7.38 (-3.28%)
MU   52.14 (-1.34%)
AMD   82.23 (+0.33%)
T   27.38 (-1.58%)
F   8.03 (-1.59%)
ACB   4.40 (-5.98%)
GILD   59.96 (-1.37%)
NFLX   488.24 (+-0.01%)
NIO   26.01 (-4.23%)
BA   160.83 (-3.90%)
DIS   124.06 (-3.34%)
S&P 500   3,400.97 (-1.86%)
DOW   27,685.38 (-2.29%)
QQQ   280.47 (-1.50%)
AAPL   115.05 (+0.01%)
MSFT   210.08 (-2.84%)
FB   277.11 (-2.70%)
GOOGL   1,584.29 (-2.98%)
AMZN   3,207.04 (+0.08%)
TSLA   420.28 (-0.08%)
NVDA   525.65 (-3.30%)
BABA   306.87 (-0.98%)
CGC   18.53 (-6.08%)
GE   7.38 (-3.28%)
MU   52.14 (-1.34%)
AMD   82.23 (+0.33%)
T   27.38 (-1.58%)
F   8.03 (-1.59%)
ACB   4.40 (-5.98%)
GILD   59.96 (-1.37%)
NFLX   488.24 (+-0.01%)
NIO   26.01 (-4.23%)
BA   160.83 (-3.90%)
DIS   124.06 (-3.34%)
S&P 500   3,400.97 (-1.86%)
DOW   27,685.38 (-2.29%)
QQQ   280.47 (-1.50%)
AAPL   115.05 (+0.01%)
MSFT   210.08 (-2.84%)
FB   277.11 (-2.70%)
GOOGL   1,584.29 (-2.98%)
AMZN   3,207.04 (+0.08%)
TSLA   420.28 (-0.08%)
NVDA   525.65 (-3.30%)
BABA   306.87 (-0.98%)
CGC   18.53 (-6.08%)
GE   7.38 (-3.28%)
MU   52.14 (-1.34%)
AMD   82.23 (+0.33%)
T   27.38 (-1.58%)
F   8.03 (-1.59%)
ACB   4.40 (-5.98%)
GILD   59.96 (-1.37%)
NFLX   488.24 (+-0.01%)
NIO   26.01 (-4.23%)
BA   160.83 (-3.90%)
DIS   124.06 (-3.34%)
S&P 500   3,400.97 (-1.86%)
DOW   27,685.38 (-2.29%)
QQQ   280.47 (-1.50%)
AAPL   115.05 (+0.01%)
MSFT   210.08 (-2.84%)
FB   277.11 (-2.70%)
GOOGL   1,584.29 (-2.98%)
AMZN   3,207.04 (+0.08%)
TSLA   420.28 (-0.08%)
NVDA   525.65 (-3.30%)
BABA   306.87 (-0.98%)
CGC   18.53 (-6.08%)
GE   7.38 (-3.28%)
MU   52.14 (-1.34%)
AMD   82.23 (+0.33%)
T   27.38 (-1.58%)
F   8.03 (-1.59%)
ACB   4.40 (-5.98%)
GILD   59.96 (-1.37%)
NFLX   488.24 (+-0.01%)
NIO   26.01 (-4.23%)
BA   160.83 (-3.90%)
DIS   124.06 (-3.34%)
Log in
LON:IQAI

IQ-AI Limited (IQAI.L) Share Forecast, Price & News

GBX 4.72
-0.04 (-0.74 %)
(As of 10/26/2020 03:14 PM ET)
Add
Compare
Today's Range
4.53
Now: GBX 4.72▼
4.73
50-Day Range
4.51
MA: GBX 5.38▼
6.20
52-Week Range
1.81
Now: GBX 4.72▼
7.35
Volume577,559 shs
Average Volume1.47 million shs
Market Capitalization£6.88 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
IQ-AI Limited, through its subsidiaries, develops software applications for the healthcare industry in Jersey and the United States. Its products include IB Clinic, a toolkit of post-processing software plug-ins for integrating into existing medical image visualization applications; IB Rad Tech, a workflow engine that processes customized workflows; IB Neuro, which analyzes MR data sets and generates parametric perfusion maps quantifying changes in contrast over time; and IB Delta Suite that performs a various fundamental radiology operations, including image co-registration, subtraction, class map generation, and export. The company also offers IB DCE, which analyzes conventional T1 weighted images and generates an array of relevant perfusion and permeability parameters; IB Diffusion that analyzes MR diffusion-weighted images and generates apparent diffusion coefficient, extrapolated b-value, IVIM, and other parameter maps; and StoneChecker, a medical software tool to aid clinical decision making by providing information about a patient's kidney stone. In addition, it provides consulting services. The company was formerly known as Flying Brands Limited and changed its name to IQ-AI Limited in October 2018. IQ-AI Limited is based in Saint Helier, Jersey.
Read More

Beat the Market (BTM) Rank™

Analyst Opinion: 0.0Community Rank: 2.3Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank™

0.46 out of 5 stars

Industry, Sector and Symbol

Stock Exchange LON
Industry Health Information Services
Sub-IndustryN/A
SectorMedical
Current SymbolLON:IQAI
Previous Symbol
CUSIPN/A
CIKN/A
Webwww.imagingbiometrics.com
PhoneN/A
Employees7

Debt

Debt-to-Equity Ratio3.49
Current Ratio4.11
Quick Ratio2.54

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual Sales£242,335.00
Price / Sales28.40
Cash FlowGBX 0.38 per share
Price / Cash Flow12.49
Book ValueGBX 0.90 per share
Price / Book5.24

Profitability

EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A

Miscellaneous

Outstanding Shares145,956,000
Market Cap£6.88 million
Next Earnings DateN/A
OptionableNot Optionable
GBX 4.72
-0.04 (-0.74 %)
(As of 10/26/2020 03:14 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive IQAI News and Ratings via Email

Sign-up to receive the latest news and ratings for IQAI and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











IQ-AI Limited (IQAI.L) (LON:IQAI) Frequently Asked Questions

How has IQ-AI Limited (IQAI.L)'s stock been impacted by COVID-19 (Coronavirus)?

IQ-AI Limited (IQAI.L)'s stock was trading at GBX 2.83 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, IQAI shares have increased by 66.9% and is now trading at GBX 4.72.
View which stocks have been most impacted by COVID-19.

Who are some of IQ-AI Limited (IQAI.L)'s key competitors?

Some companies that are related to IQ-AI Limited (IQAI.L) include Induction Healthcare Group (INHC), Diagnos (ADK), CardioComm Solutions, Inc. (EKG.V) (EKG), 1st Group Limited (1ST.AX) (1ST), Alcidion Group Limited (ALC.AX) (ALC), Cann American (CNNA), CannaOne Technologies (CNONF), CloudMD Software & Services (DOC), CloudMD Software & Services (DOCRF), Cogstate Limited (CGS.AX) (CGS), CompuMed (CMPD), Corum Group Limited (COO.AX) (COO), EGF Theramed Health (EVAHF), Emerald Clinics (EMD) and eWELLNESS HEALTHCARE (EWLL).
View all competitors.

What other stocks do shareholders of IQ-AI Limited (IQAI.L) own?

Based on aggregate information from My MarketBeat watchlists, some companies that other IQ-AI Limited (IQAI.L) investors own include The Macerich (MAC), Merck & Co., Inc. (MRK), Pfizer (PFE), The Scotts Miracle-Gro (SMG), Xilinx (XLNX), Arista Networks (ANET), Amgen (AMGN), Advanced Micro Devices (AMD), Akers Biosciences (AKER) and Aimmune Therapeutics (AIMT).

Who are IQ-AI Limited (IQAI.L)'s key executives?

IQ-AI Limited (IQAI.L)'s management team includes the following people:
  • Mr. Trevor Edward Brown M.B.A., CEO & Director (Age 74, Pay $65k)
  • Mr. David W. J. Smith, Chief Operating Officer
  • Donald Reid, Sec.

What is IQ-AI Limited (IQAI.L)'s stock symbol?

IQ-AI Limited (IQAI.L) trades on the London Stock Exchange (LON) under the ticker symbol "IQAI."

How do I buy shares of IQ-AI Limited (IQAI.L)?

Shares of IQAI and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What is IQ-AI Limited (IQAI.L)'s stock price today?

One share of IQAI stock can currently be purchased for approximately GBX 4.72.

How big of a company is IQ-AI Limited (IQAI.L)?

IQ-AI Limited (IQAI.L) has a market capitalization of £6.88 million and generates £242,335.00 in revenue each year. IQ-AI Limited (IQAI.L) employs 7 workers across the globe.

What is IQ-AI Limited (IQAI.L)'s official website?

The official website for IQ-AI Limited (IQAI.L) is www.imagingbiometrics.com.

This page was last updated on 10/26/2020 by MarketBeat.com Staff
Receive Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.